| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/04/2009 | EP2029535A1 Isoindole derivatives useful for treating pain, gastrointestinal diseases and cancer |
| 03/04/2009 | EP2029234A1 Treatment of gastrointestinal disorders with cgrp-antagonists |
| 03/04/2009 | EP2029233A2 Treatment of gastrointestinal disorders with cgrp antagonists |
| 03/04/2009 | EP2029150A1 Extract of herbal and the composition containing the same |
| 03/04/2009 | EP2029145A2 Pyrrolopyrimidine compounds and their uses |
| 03/04/2009 | EP1695983B1 Glucagon-like peptide-1 analogs |
| 03/04/2009 | EP1506951B1 Method for the preparation of total salvianolic acid |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1472209B1 Lipoxin a4 analogs |
| 03/04/2009 | EP1452527B1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 03/04/2009 | EP1401863B1 Somatostatin-dopamine chimeric analogs |
| 03/04/2009 | EP1230243B1 Poycyloalkylpurines as adenosine receptor antagonists |
| 03/04/2009 | EP1078006B1 Diagnosis and treatment of hepatic disorders |
| 03/04/2009 | CN101379040A Muscarinic receptor antagonists |
| 03/04/2009 | CN101378769A Bile preparations for gastrointestinal disorders |
| 03/04/2009 | CN101378745A Pharmaceutical composition comprising meglitinide for prevention of hepatic fibrosis |
| 03/04/2009 | CN101378743A Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3-propanaediol derivative as active ingredient, and method for treatment of inflammatory bowel disease |
| 03/04/2009 | CN101378720A Fluoride composition and methods for dental mineralization |
| 03/04/2009 | CN101376624A Cinnamomum kanehirae Hayata pimelie kelone compound for liver protection |
| 03/04/2009 | CN101376018A Chinese medicine for treating chronic cholangitis and angiocholitis |
| 03/04/2009 | CN101376017A Chinese medicine for treating constipation and preparation method thereof |
| 03/04/2009 | CN101376008A Pure medicinal formulation for tonifying kidney and dreplenishing essence and preparation method thereof |
| 03/04/2009 | CN101376004A (Compound honeybee and bovine colostrums) medicine for removing food retention and promoting digestion |
| 03/04/2009 | CN101376003A Pollen medicine for removing food retention and promoting digestion |
| 03/04/2009 | CN101376001A Pure medicinal formulation for strengthening spleen and regulating stomach and preparation method thereof |
| 03/04/2009 | CN101375995A (Compound honeybee and bovine colostrums) medicine for tonifying qi |
| 03/04/2009 | CN101375994A (Compound honeybee and bovine colostrums) medicine for replenishing vital essence |
| 03/04/2009 | CN101375976A Moxa roll containing cattail pollen charcoal powder |
| 03/04/2009 | CN101375972A Health oral liquid and its preparation |
| 03/04/2009 | CN101375951A Medicine composition for treating hepatitis B |
| 03/04/2009 | CN101375947A Compound Macleaya cordata injection and preparation method |
| 03/04/2009 | CN101375934A Chinese medicine oral liquid with heat-clearing and detoxicating, antibiotic and anti-dysentery functions as well as application thereof for livestock and poultry |
| 03/04/2009 | CN101375925A Pharmaceutical combination for preventing birth-defect and improving memory |
| 03/04/2009 | CN101375917A Hepatitis B health-care oral liquid and preparation method thereof |
| 03/04/2009 | CN101375868A Technique for extracting pine and cypress vigor element from branches and leaves, roots and barks, and flower bulbs of pine and cypress |
| 03/04/2009 | CN101375867A Oligosaccharide of mycelium of Hericium erinaceus extracted from fermentation product of mycelium of Hericium erinaceus and uses thereof |
| 03/04/2009 | CN101375866A Chinese medicinal composition for treating disease of stomach |
| 03/04/2009 | CN101375864A Biological products with treatment use and preparation method thereof |
| 03/04/2009 | CN101375855A Compound niacin norfloxacin injection and preparation method |
| 03/04/2009 | CN101375842A Application of lignan of biphenyl cyclooctene series in preparing anti-hepatitis B virus medicament |
| 03/04/2009 | CN101375841A Daucane type sesquiterpenes and preparation method and application thereof |
| 03/04/2009 | CN101375837A Medicament composition for treating dermatopathy as well as preparation method and use thereof |
| 03/04/2009 | CN101375836A Compound gentamicin-micronomicin injection and preparation method |
| 03/04/2009 | CN100465183C A method of comprehensive utilizing schisandra fruits |
| 03/04/2009 | CN100465171C A preparation method of potassium sodium dehydroandroan drographolide succinate, a potassium sodium dehydroandroan drographolide succinate preparation and a preparation method thereof |
| 03/04/2009 | CN100464765C A preparation method of constipation relieving powders |
| 03/04/2009 | CN100464762C An oral anti-inflammation disinfectant and a preparation method thereof |
| 03/04/2009 | CN100464761C An application of houseleek in preparing medicines for treating toothache |
| 03/04/2009 | CN100464755C A traditional Chinese medicine preparation with functions of immunological regulation for anti-chemical damage |
| 03/04/2009 | CN100464753C Foscarnet sodium compositions |
| 03/04/2009 | CN100464752C Granisetron cataplasm and a preparation method thereof |
| 03/04/2009 | CN100464749C 5HT4 partial agonist pharmaceutical compositions |
| 03/04/2009 | CN100464735C A preparation method of hydro-acupuncture of liver cell growth promoting factors |
| 03/04/2009 | CN100464734C A desensitizing anticarious gel and a preparation method thereof |
| 03/03/2009 | US7498435 One amine is substituted with a fused heterocyclic ring and the other with a fused heterocyclic ring or phenyl ring, e.g., N2,N4-Bis(3,4-ethylenedioxyphenyl)-5-cyano-2,4-pyrimidinediamine; inhibit IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators such as histamine |
| 03/03/2009 | US7498406 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/03/2009 | US7498360 Adminisering prostaglandin into ear |
| 03/03/2009 | US7498358 Human ADAM-10 inhibitors |
| 03/03/2009 | US7498347 improved metabolic stability; gastrointestinal conditions like hypermotility, irritable bowel syndrome (IBS), constipation or diarrhea; amidation |
| 03/03/2009 | US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
| 03/03/2009 | US7498323 Spiro-piperidine compounds and medicinal use thereof |
| 03/03/2009 | US7498308 The analogs are resistant to diaminopeptidase IV degradation and bind zinc; are active over an extended time in vivo |
| 03/03/2009 | US7498143 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 03/03/2009 | US7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies |
| 03/03/2009 | US7498021 Peptide that binds to integrins |
| 03/03/2009 | CA2410880C 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 03/03/2009 | CA2351617C Method for inhibiting dental resorptive lesions |
| 02/26/2009 | WO2009026276A1 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 02/26/2009 | WO2009026158A2 Inflammation-regulating compositions and methods |
| 02/26/2009 | WO2009025478A1 Indole and indazole compounds as an inhibitor of cellular necrosis |
| 02/26/2009 | WO2009025477A1 Indole compounds as an inhibitor of cellular necrosis |
| 02/26/2009 | WO2009025117A1 Cdca1 peptide and pharmaceutical agent comprising the same |
| 02/26/2009 | WO2009024677A2 Use of hyaluronic acid for preparing compositions for improving the function of skin, eye and mucous membrane protection |
| 02/26/2009 | WO2009024491A1 Use of mglur5 antagonists for the treatment of gerd |
| 02/26/2009 | WO2009024022A1 Fatty acid bile acid conjugates and medical uses thereof |
| 02/26/2009 | WO2009023918A1 Method of producing plant extract formulations |
| 02/26/2009 | WO2008030579A3 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 02/26/2009 | WO2008022761A3 Rapamycin and its derivatives for the treatment of liver-associated fibrosing disorders |
| 02/26/2009 | US20090054526 Inhibitors of anorexic lipid hydrolysis for the treatment of eating disorders |
| 02/26/2009 | US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis |
| 02/26/2009 | US20090054490 Methods for the treatment of gerd with mglur5 antagonists |
| 02/26/2009 | US20090054480 Novel quinuclidine carbamate derivatives and medicinal compositions containing the same |
| 02/26/2009 | US20090054462 Hydroisoindoline tachykinin receptor antagonists |
| 02/26/2009 | US20090054461 Pharmaceutical composition comprising a 1-(3-chlorophenyl)-3-alkylpiperazine for treating apetite disorder |
| 02/26/2009 | US20090054459 Substituted indoles |
| 02/26/2009 | US20090054437 Nitrocatechol Derivatives as Comt Inhibitors |
| 02/26/2009 | US20090054424 Optically active pyridine derivative and a medicament containing the same |
| 02/26/2009 | US20090054378 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines |
| 02/26/2009 | US20090054359 Compositions and their uses directed to diacylglycerol acyltransferase 1 |
| 02/26/2009 | US20090054354 Drug and food or drink for improving pancreatic functions |
| 02/26/2009 | US20090054329 Composition with docosapentaenoic acid |
| 02/26/2009 | US20090054319 Methods and Compositions for the Treatment of Hypertension and Gastrointestinal Disorders |
| 02/26/2009 | US20090054302 Methods and Preparations For Curing Clinically Ill Patients |
| 02/26/2009 | US20090053808 Compositions and methods for inhibiting the expression of anti-apoptopic genes |
| 02/26/2009 | US20090053309 Adhesive compositions for the treatment of xerostomia |
| 02/26/2009 | US20090053234 Methods of Preventing or Treating Inflammatory or Autoimmune Disorders by Administering Integrin ALPHAVBETA3 Antogonists in Combination with other Prophylactic or Therapeutic Agents |
| 02/26/2009 | US20090053231 Optical Disc Apparatus |
| 02/26/2009 | US20090053230 Anti-ox40l antibodies and methods using same |
| 02/26/2009 | CA2734577A1 Inflammation-regulating compositions and methods |
| 02/26/2009 | CA2697081A1 5-(4-(haloalkoxy)phenyl)pyrimidine-2-amine compounds and compositions as kinase inhibitors |